Co-Authors
This is a "connection" page, showing publications co-authored by Luca Quartuccio and Arianna Damiani.
Connection Strength
0.386
-
Old and new antirheumatic drugs for the treatment of COVID-19. Joint Bone Spine. 2020 05; 87(3):195-197.
Score: 0.220
-
Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al. Ann Rheum Dis. 2020 Aug 04.
Score: 0.056
-
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Ann Rheum Dis. 2020 Jul 06.
Score: 0.056
-
Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives. Isr Med Assoc J. 2020 04; 22(4):203-210.
Score: 0.055